InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Donnelly Scott C, 董事长兼首席执行官. Director active across 2 companies, notably Medtronic plc. In total, 19 filings have been published. History available since 3 May 2021. The latest transaction was disclosed on 27 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Donnelly Scott C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
2,111 股0Ordinary SharesSEC:0001233158-26-000008:0
207 股@ US$81.900.0000% mcap2.8% 占其流量Ordinary SharesSEC:0001233158-26-000008:1
13,017 股0Common StockSEC:0001233158-26-000006:0
219,619 股@ US$49.5831.7% 占其流量Common StockSEC:0001233158-26-000004:0
2,083 股@ US$84.0430.3% 占其流量Ordinary SharesSEC:0001613103-25-000063:0
216 股@ US$84.603.2% 占其流量Ordinary SharesSEC:0001613103-25-000063:1
47,232 股0Common StockSEC:0000217346-25-000037:0
192 股@ US$80.892.9% 占其流量Ordinary SharesSEC:0001613103-24-000047:0
2,165 股@ US$80.8632.2% 占其流量Ordinary SharesSEC:0001613103-24-000028:0
32,547 股0Common StockSEC:0000217346-24-000039:0
194,546 股@ US$44.3140.7% 占其流量Common StockSEC:0000217346-24-000022:0
46,002 股0Common StockSEC:0000217346-23-000037:0
1,930 股@ US$90.6831.5% 占其流量Ordinary SharesSEC:0001613103-23-000025:0
44,583 股0Common StockSEC:0001062993-23-005908:0
222,319 股@ US$39.7041.8% 占其流量Common StockSEC:0001062993-23-004609:0
1,697 股0Ordinary SharesSEC:0001127602-22-013284:0
38,997 股0Common StockSEC:0001062993-22-006721:0
136,854 股@ US$28.470.022% mcap100.0% 占其流量Common StockSEC:0001062993-22-005563:0
1,334 股0Ordinary SharesSEC:0001127602-21-015313:0
19 条申报中的 19 条
About Donnelly Scott C
DONNELLY SCOTT C is President and Chief Executive Officer. He has 19 filings in total, and across the 19 sampled filings the transactions are of Attribution type, with buy and sell amounts at 0. The recent filings span 2021-05-04 to 2026-04-29, mainly involving TEXTRON INC and Medtronic plc.
